Shingrix Inj

Shingrix is a vaccine designed to protect against shingles (herpes zoster), a painful rash caused by the reactivation of the varicella-zoster virus, the same virus that causes chickenpox. Shingles can lead to severe nerve pain, known as postherpetic neuralgia (PHN), and other complications, particularly in older adults. Shingrix is highly effective in preventing shingles and its associated complications. Shingrix is a recombinant, adjuvanted vaccine. It contains a non-live antigen, glycoprotein

• ✓Recombinant adjuvanted zoster vaccine (RZV) by GlaxoSmithKline for adults 50+
• ✓Over 90% efficacy in preventing shingles and postherpetic neuralgia across all age groups
• ✓Non-live vaccine safe for immunocompromised individuals
• ✓Two-dose series (0 and 2-6 months apart) for long-lasting protection against shingles

Requires 2 doses